Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CETP inhibitors(Cholesteryl ester transfer protein inhibitors), NPC1L1 inhibitors(Niemann-Pick C1-like protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC32H31F9N4O5 |
InChIKeyNRWORBQAOQVYBJ-GJZUVCINSA-N |
CAS Registry866399-87-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque, Atherosclerotic | Phase 3 | US | 16 May 2024 |